 effect sucralf lumin stasi recoveri chamber rat gastric mucosa taurocholate-induc damag gastric chamber model sucralf lumin stasi rat gastric mucosa develop hemorrhag eros subsequ exposur minut hcl mM sodium taurochol nat protect sucralf inhibit cyclooxygenas activ sucralf studi indomethacin pretreat depth micron magnitud pH unit juxtamucos pH gradient sucralf restor paramet level characterist normal mucosa cytoprotect effect sucralf prostaglandin-independ part consequ sucralfate-induc increas thick juxtamucos pH layer abil sucralf inevit develop hemorrhag eros gastric mucosa nat mg sucralf mM hcl minut subsequ exposur mucosa nat averag lesion area cytoprotect properti abil sucralf recoveri process damag indomethacin pretreat studi antimoni microelectrod indomethacin pretreat reduct depth magnitud pH gradient plasma efflux mucosa exposur bile salt studi sucralf capabl prevent attenu acut damag agent capabl sequenc event hemorrhag stomach